Islet cell autoantigens in type 1 diabetes

European Journal of Clinical Investigation

Volumn 26, Issue 10, 1996, Pages 827-838

  Christie, M R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PRIORITY JOURNAL; REVIEW;

EID: 0029853146     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1996.tb02126.x     Document Type: Review

References (81)

1. Bottazzo G, Florin Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:279-1283.
2. Gepts W, De Mey J. Islet cell survival detrmined by morphometry: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 1978;27(Suppl. 1):251-61.
3. Nerup J, Andersen O, Bendixen G et al. Cell mediated immunity in diabetes mellitus. Proc R Soc Med 1974;67:506-11.
4. Todd JA. Genetic analysis of susceptibility to Type I diabetes. Springer Semin Immunopathol 1992;14:33-58.
5. Bach J-F. Insulin-dependent diabetes as an autoimmune disease. Endocrine Rev 1994;14:516-42.
6. Nerup J, Mandrup-Poulsen T, Molvig J. The HLA IDDM association: implications for etiology and pathogenesis of IDDM. Diabetes Metab. Rev 1987;3:779-802.
7. The Canadian-European Randomized Control Trial Group. Cyclosporin-induced remission of IDDM after early intervention: association of 1 y of cyclosporin treatment with enhanced insulin secretion. Diabetes 1988;37:1574-82.
8. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate pancreatic islet cell proteins. Nature 1982; 298:167-9.
9. Baekkeskov S, Aanstoot H, Christgau S et al. Identification of the 64 k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6.
10. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J Exp Med 1990;172:789-94.
11. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and, 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule 1A-2 (ICA512). J Clin Invest 1995;96:1506-11.
12. Baekkeskov S, Aanstoot HJ, Fu Q et al. The glutamate decarboxylase and 38 kDa autoantigens in type 1 diabetes: Aspects of structure and epitope recognition. Autoimmunity 1993;15: 24-6.
13. Karounos DG, Thomas JW. Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes 1990;39:1085-90.
14. Karounos DG, Wolinsky JS, Thomas JW. Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 1993;150:3080-5.
15. Boitard C, Villa MC, Becourt C et al. An islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci USA 1992;89:172-6.
16. Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS. Identification and cloning of a granule autoantigen (carboxy-peptidase-H) associated with type I diabetes. J Endocrinol Metab 1991;73:1197-201.
17. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human antoantigens. Diabetes 1992;41:183-6.
18. Rabin DU, Pleasic SM, Shapiro JA et al. Islet antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994;152:3183-8.
19. Pietropaolo M, Castano L, Babu S et al. Islet cell autoantigen 69 kDa (ICA 69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993;92: 359-71.
20. Nayak RC OMA Rabizadeh A, Srikanta S, Eisenbarth GS. Cytoplasmic islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985;34:617-19.
21. Dotta F, Previti M, Lenti L, Dionisi S, Casetta B, DErme M, Eisenbarth GS, Di MU. GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia 1995;38:1117-21.
22. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993;91:350-6.
23. Palmer J, Asplin C, Clemons P, Lyen K, Tapati O, Raghu P, Pauquette T. Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science 1982;222:1337-8.
24. Elias D, Markovits D, Reshev T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 1990;87:1576-80.
25. Atkinson MA, Bowman MA, Kao KJ et al. Lack of immune responsiveness to bovine serum albumin in insulin- dependent diabetes. New Engl J Med 1993;329:1853-8.
26. Roep BO, Kallan AA, Hazenbos W et al. T-cell reactivity to 38 kDa insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 1991;337:1439-41.
27. Roep BO, Arden SD, De VR, Hutton JC. T-cell clones from type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990;345:632-4.
28. Arden S, Roep B, Neophytou P et al. Imogen 38: A novel 38 kDa autoantigen recognised by T-cells from a newly diagnosed type 1 diabetic patient. Autoimmunity 1995;21:47
29. Kim J, Namchuk M, Bugawan T et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 1994;180:595-606.
30. Lampasona V, Ferrari M, Bosi E, Pastore MR, Bingley PJ, Bonifacio E. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J Autoimmun 1994;7:665-74.
31. Christie M, Landin Olsson M, Sundkvist G, Dahlquist G, Lernmark A, Baekkeskov S. Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 1988;31:597-602.
32. Baekkeskov SLM, Kristensen JK, Srikanta S et al. Antibodies to a 64000-Mr human islet cell protein precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987;79:926-34.
33. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff man syndrome. New Engl J Med 1990;322:1555-60.
34. Erlander MG, Tillakaratne NJK, Feldblum S, Pate N, Tobin AJ. Two genes encode distinct glutamate decarboxylases. Neuron 1991;7:91-100.
35. Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-50.
36. Li L, Hagopian WA, Brashear HR, Daniels T, Lernmark A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff man syndrome patients. J Immunol 1994; 152:930-4.
37. Kaufman DL, Clare-Salzer M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
38. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulins in non-obese diabetic mice. Nature 1993; 366:72-5.
39. Atkinson MA, Kaufman DL, Campbell L et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992;339:458-9.
40. Christie MR, Tun RYM, Lo SSS et al. Antibodies to glutamic acid decarboxylase and tryptic fragments of islet 64 kDa antigen as distinct markers for the development of insulin-dependent diabetes. Studies with identical twins. Diabetes 1992;41:782-7.
41. Bosi E, Becker F, Bonifacio E et al. Progression to type I diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 1991;40:977-84.
42. Christie MR, Genovese S, Cassidy D et al. Antibodies to islet 37 k-antigen, but not to glutamate decarboxylase, discriminate rapid progression to insulin-dependent diabetes mellitus in endocrine autoimmunity. Diabetes 1994;43:1254-9.
43. Genovese S, Bonifacio E, McNally JM et al. Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35: 385-8.
44. Wagner R, McNally JM, Bonifacio E et al. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with b-selective GAD-specific islet cell antibodies. Diabetes 1994;43:851-56.
45. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New Engl J Med 1985;313:353-60.
46. Sibley RK SDE Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985;53:132-44.
47. Miller B, Appel M, O'Neil J, Wicker L. Both the LYT-2 + and L3T4 + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988;140:52-8.
48. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.
49. Harrison LC, Honeyman MC, DeAizpurua HJ et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993;341:1365-9.
50. Gianani R, Pugliesi A, Bonner-Weir S et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 1992;41:347-53.
51. Butler MH, Solimena M, Dirkx R, Hayday A, De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff man syndrome. J Exp Med 1993;178:2097-106.
52. Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 1994;43:968-75.
53. Daw K, Powers AC. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 1995;44:216-20.
54. Richter W, Endl J, Eiermann TH et al. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci 1992;89:8467-71.
55. Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of glutamate decarboxylase. Proc Natl Acad Sci USA 1993;90:2832-36.
56. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991;88:10252-56.
57. Gelber C, Paborsky L, Singer S et al. Isolation of nonobese diabetic mouse T-cells that recognize novel autoatingens involved in the early events of diabetes. Diabetes 1994;43:33-9.
58. Christie M Vohra G, Champagne P, Daneman D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J Exp Med 1990;172:789-94.
59. Christie MR, Hollands JA, Brown TJ, Michelsen BK, Delovitch TL. Detection of pancreatic islet 64000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 1993;92:240-8.
60. Bingley PJ, Christie MR, Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994;43:1304-10.
61. Genovese S, Bingley PJ, Bonifacio E et al. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 1994;344:756.
62. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994;13:505-14.
63. Solimena S, Dirkx R, Hermel J-M et al. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 1996;15:2102-14.
64. Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 1996;45:18161-70.
65. Wasmeier C, Hutton JC. Molecular cloning of phogrin, a protein tyrosine phosphatase homologue localised to insulin secretory granule membranes. J Biol Chem 1996;271 (in press).
66. Roll U, Christie MR, Fuchtenbusch M et al. Perinatal autoimmunity in offspring of diabetic parents. The Geman multicenter BABY-DIAB study: Detection of humoral immune responses to islet antigen in early childhood. Diabetes 1996;45:967-73.
67. Warram J, Krolewski A, Kahn C. Determinants of IDDM and perinatal mortality in children of diabetic mothers. Diabetes 1988;37:1328-34.
68. Theofilopoulos AN. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today 1995;16:90-8.
69. Kaufman DL, Erlander MG, Clare-Salzer M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89:283-92.
70. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994;180:1979-84.
71. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-9.
72. Bonifacio E, Bingley PJS M, Dean BM, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-9.
73. Vardi P, Ziegler AG, Mathews JH et al. Concentration of insulin autoantibodies at onset of type I diabetes: Inverse log-linear correlation with age. Diabetes Care 1988;11:736-9.
74. Nuovo JA, Baker JJ, Wartofsky L, Lukes YG, Burman KD. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 1988;37:317-20.
75. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS. Lite-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 1989;38:1320-5.
76. Hagopian WA, Sanjeevi CB, Kockum I et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995;95:1505-11.
77. Petersen JS, Hejnaes KR, Moody A et al. Detection of GAD(65) antibodies in diabetes and other autoimmune disease using a simple radioligand assay. Diabetes 1994;43:459-67.
78. Rowley MJ, Mackay IR, Chen Q-Y, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992;41:548-51.
79. Ongagna JC, LevyMarchal C. Anti-37 kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies. Diabetologia 1995;38:370-5.
80. Bonifacio E, Genovese S, Braghi S et al. Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity. Diabetologia 1995;38:816-22.
81. Harrison LC. Islet cell autoantigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 1992;13: 348-52.